LocusBio Profile Banner
Locus Biosciences Profile
Locus Biosciences

@LocusBio

Followers
1K
Following
321
Media
62
Statuses
301

Revolutionizing the treatment of bacterial disease.

RTP, North Carolina
Joined May 2013
Don't wanna be here? Send us removal request.
@LocusBio
Locus Biosciences
1 year
We’re thrilled to announce we've received funding from @BARDA to advance LBP-EC01, our first-in-class #CRISPR-engineered #bacteriophage therapy, into Part 2 of our Phase 2 ELIMINATE trial for treating #UTIs caused by drug-resistant E. coli. Read more ➡️
Tweet media one
1
7
20
@LocusBio
Locus Biosciences
10 months
With #AntibioticResistance on the rise, Locus is pioneering a new approach using bacteriophages to combat infections and other diseases like #IBD. Our AI-designed phage therapy selectively targets harmful bacteria. Read more about our efforts in @WIRED.
0
2
7
@LocusBio
Locus Biosciences
10 months
RT @cenmag: Largest ever phage therapy trial shows promise for UTI treatment. Urinary tract–infecting E. coli are increasingly antibiotic r….
0
2
0
@LocusBio
Locus Biosciences
11 months
RT @CrisprMedicine: 🫁 𝐂𝐑𝐈𝐒𝐏𝐑-𝐞𝐝𝐢𝐭𝐞𝐝 𝐩𝐡𝐚𝐠𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐞𝐥𝐢𝐦𝐢𝐧𝐚𝐭𝐞𝐬 𝐔𝐓𝐈 𝐢𝐧 𝐏𝐡𝐚𝐬𝐞 2 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥 🫁. US-based Locus Biosciences recently reported….
0
3
0
@LocusBio
Locus Biosciences
11 months
The next phase is underway with dosing now started in the randomized, controlled, and blinded Part 2, backed by @BARDA. With 150M people affected by UTIs annually, innovative treatments like LBP-EC01 are vital. Stay tuned for more updates! #PhageTherapy 
0
1
2
@LocusBio
Locus Biosciences
11 months
#ICYMI: Positive results from Part 1 of our Phase 2 ELIMINATE trial are published in The Lancet Infectious Diseases! LBP-EC01, our CRISPR-Cas3 engineered #bacteriophage, targets #UTIs caused by #AMR & #MDR E. coli.
Tweet media one
1
3
7
@LocusBio
Locus Biosciences
11 months
Exciting news! Locus has been awarded $4.1M from @CARB_X to support the development of an engineered #bacteriophage therapy targeting infections caused by antimicrobial-resistant (#AMR) and multi-drug-resistant (#MDR) K. pneumoniae.
Tweet media one
0
6
10
@LocusBio
Locus Biosciences
11 months
RT @ncbiotech: NCBiotech portfolio company Locus Bio has announced positive results from the first portion of its Phase 2 trial in drug-res….
0
2
0
@LocusBio
Locus Biosciences
11 months
Positive results from Part 1 of our Phase 2 ELIMINATE trial evaluating genetically engineered bacteriophage therapy, LBP-EC01, to treat #UTIs were published in @TheLancet Infectious Diseases. Additionally, dosing has begun in Part 2 portion of this study.
Tweet media one
1
4
7
@LocusBio
Locus Biosciences
1 year
Check out this @TheBioBuzz article on promising new #microbiome-based approaches to medicine including #PhageTherapy.
0
1
3
@LocusBio
Locus Biosciences
1 year
Drug-resistant infections claim ~5M lives annually. At Locus, we’re harnessing the power of #bacteriophages to target and destroy specific bacteria. Our CEO discusses our novel approach in this @voxdotcom article.
0
1
5
@LocusBio
Locus Biosciences
1 year
Our CEO, Paul Garofolo, discussed Locus' work to revolutionize treatments for bacterial infections & other diseases like #IBD with engineered bacteriophage therapies that preserve the microbiome. Learn about our advancements in #precisionmedicine.
0
1
4
@LocusBio
Locus Biosciences
1 year
Excited for #BIO2024? Want to learn about our work to develop #precisionmedicines including bacteriophage-based therapies to combat antibiotic resistance and treat #immunology diseases including inflammatory bowel disease (#IBD)? Let’s connect.
Tweet media one
0
1
3
@LocusBio
Locus Biosciences
1 year
Celebrating 9 Years of Innovation and Impact! Pioneering #precisionmedicine with engineered bacteriophage therapy, combating antibiotic-resistant infections, and #immunology diseases like #IBD. Grateful for support as we continue revolutionizing treatment! #LocusTurns9
Tweet media one
0
0
3
@LocusBio
Locus Biosciences
1 year
We’re excited to attend #DDW2024! As Locus develops #precisionmedicines to treat #immunology diseases including #IBD, we look forward to meeting with researchers, clinicians, and industry leaders to discuss how together we can push the boundaries of medicine.
Tweet media one
0
0
4
@LocusBio
Locus Biosciences
1 year
Excited to join the @ESCMID Global Conference & CARB-X Investor Day! 🌍 As pioneers in bacteriophage-based precision medicine, Locus looks forward to insightful discussions & collaborations driving innovation in combatting antibiotic resistance. #ESCMIDGlobal #CARBX #AMR.
0
0
0
@LocusBio
Locus Biosciences
1 year
Happy #DNADay24! We honor the discovery of DNA's double helix structure and the remarkable advancements it has led to revolutionize medicine. Locus is dedicated to pushing #biotechnology boundaries, creating a new class of bacteriophage biotherapeutics using #PrecisionMedicine.
Tweet media one
0
0
2
@LocusBio
Locus Biosciences
1 year
🎉 Thrilled to announce that the Locus team exceeded our fundraising goal of $20,000 for the @CrohnsColitisFn Triangle Take Steps Walk!🚶‍♂️💙 We proudly walked in solidarity to raise #IBDAwareness. Huge thanks to all supporters!
Tweet media one
Tweet media two
Tweet media three
0
1
2
@LocusBio
Locus Biosciences
1 year
Locus is excited to be a 2024 Triangle Take Steps event sponsor to raise #IBD awareness and support the @CrohnsColitisFn! As a Company, we're exploring how #bacteriophages and #PrecisionMedicine may help treat GI conditions including IBD. Learn more.
0
0
1
@LocusBio
Locus Biosciences
1 year
Thrilled to be at the 6th Bacteriophage Therapy Summit by Hanson Wade Group today. Looking forward to dialogue around realizing the promise of #bacteriophage tx to address #AMR & other health issues. Interested in connecting? Email info@locus-bio.com.
1
0
5
@LocusBio
Locus Biosciences
1 year
RT @statnews: With phage therapy, researchers sharpen another arrow in the quiver against antibiotic resistance.
0
8
0